Effects Of The Sevoflurane And Magnesium On Maternal Oxidative Stress, İnflammation And Fetal Brain Histopathology


Creative Commons License

Özdemir Ç., Koca G., İnan M. A., Işık B.

ASPA 2022, İstanbul, Türkiye, 14 - 16 Ekim 2022, ss.140-142

  • Yayın Türü: Bildiri / Tam Metin Bildiri
  • Basıldığı Şehir: İstanbul
  • Basıldığı Ülke: Türkiye
  • Sayfa Sayıları: ss.140-142
  • Gazi Üniversitesi Adresli: Evet

Özet

INTRODUCTION/ PURPOSE: Studies have demonstrated that exposure to anesthetic agents during neurodevelopment triggers neurodegeneration and subsequent long-term neurobehavioral abnormalities(1). The developing brain is vulnerable to the harmful effects of anesthetics. Magnesium sulfate has been shown to protect the nervous system from inflammation and ischemic episodes(2-3). We aimed to evaluate the effects of sevoflurane and/or MgSO4, the most commonly used anesthetic and sedative agent in obstetric anesthesia, on maternal oxidative stress and fetal brain histopathology in midgestational rats. MATERIALS and METHOD: Pregnant rats were randomly divided into 4 groups on the 14th. day. Group C (control) were exposed to 100% oxygen for 2 hours. Group Sv (sevoflurane) were also exposed to 2.3% sevoflurane with oxygen for 2 hours. MgSO4 was injected intraperitoneally at a dose of 270 mg/kg to the rats in Group Sv+MgSO4 and group MgSO4. Sevoflurane exposure in Group Sv+MgSO4 started 30 minutes after injection. Inflammatory and oxidative markers (as an IL-6, IL-10, TNF-α, TAS, TOS, OSİ) and histopathological evaluation were performed in maternal blood or fetal brain tissue. FINDINGS: Rats in Group Sv had higher serum TNF-α [159.641pg/mL (Median)] compared to Group C [71,943 pg/ml (Median)] (P=0.04). There was no significant difference in IL-6, IL-10 and serum TAS, TOS and OSI (P<0.05) Results are shown in Table 1. In the histopathological evaluation of fetal brains, no findings suggesting damage pathways such as apoptosis, autophagy, and inflammation were found. DISCUSSION / CONCLUSION: In pregnant rats, exposure to anesthetic doses of sevoflurane during mid-pregnancy did not cause an increase in inflammatory and oxidative stress markers other than TNF-α in maternal rats and histopathological changes in fetal brain tissue. For this reason, in clinical dose range neither sevoflurane nor MgSO4+sevoflurane were not negative effect on maternal oxidative stress or fetal histopathological changes. But, TNF-alpha elevation in Group Sv should be taken into account.